Skip to main content
. Author manuscript; available in PMC: 2012 Feb 20.
Published in final edited form as: AIDS. 2011 Feb 20;25(4):513–518. doi: 10.1097/QAD.0b013e328343817b

Table 1. Candidate study of previously reported variants associated with HIV-1 susceptibility.

Column 1) Reported candidate gene; Column 2) The identical candidate SNPs originally identified and available after passing QC on the 1M-Duo chip; Column 3) The identical candidate SNPs originally identified and available via a proxy found on the 1M-Duo chip; Column 4) The proxy SNP and the corresponding r2 value as identified in the YRI population for the candidate SNP identified in column 3; Column 5) the lowest p-value for the SNPs identified in Column 2, or Column 4, if a proxy SNP; Column 6) the lowest p-value for SNPs linked to the candidate gene; Column 7) The number of SNPs tested in each candidate gene; Column 8) gene-wide corrected p-value for the lowest p-value identified within the candidate gene; Column 9) set-wide corrected p-value for the lowest p-value identified per candidate gene and corrected for all candidate genes investigated; Column 10) genome-wide corrected p-value for the lowest p-value identified per candidate gene; and Column 11) Studies reporting corresponding candidate SNPs and genes

Gene previously associated SNPs previously associated SNPs represented by an LD proxy Closest proxy (r2 in YRI) SNP replication P lowest P in gene Number of SNPs tested in gene Gene-Wide correction Set-wide correction Genome- wide correction Reference
ABCB1 rs1045642 0.87 0.004 105 0.42 1 1 Fellay Jet al.,2002; Lancet, 359:30–36
APOBEC3G 0.26 4 1 1 1 Valcke et al., 2006; AIDS, 20:1984–1986
CCL2 rs1024610
rs1024611
0.54 0.0008 175 0.14 0.96 1 Modi et al., 2003; AIDS, 17:2357–2365
CCL3 rs1719134 rs1719126 (0.43) 0.41 0.1 3 0.3 1 1 Gonzalez et al., 2001; Proc Natl Acad Sci USA, 98: 5199–5204
CCL4 0.15 6 0.9 1 1 Colobran et al., 2005; J Immunol, 174:5655–5664
CCL5 rs2107538
rs2280789
0.68 0.04 10 0.4 1 1 McDermott et al., 2000; AIDS, 14:2671–2678
Gonzalez et al., 2001; Proc Natl Acad Sci USA, 98: 5199–5204
An et al., 2002; Proc Natl Acad Sci USA, 99:10002–10007
Fernandez et al., 2003; AIDS Res Hum Retroviruses, 19: 349–352
Liu et al., 2004; J Infect Dis, 190:1055–1058
CCL7 0.11 3 0.33 1 1 Modi et al., 2003; AIDS, 17:2357–2365
CCL11 0.2 13 1 1 1 Modi et al., 2003; AIDS, 17:2357–2365
CCR5 0.19 3 1 1 1 [3] Dean et al., 1996
[4] Samson et al., 1996
Huang et al.,1996; Nat Med, 2:1240–1243
CD209 0.07 19 1 1 1 Martin et al., 2004; J Virol, 78:14053–14056
CD4 rs28919570 0.21 0.007 33 0.23 1 1 Oyugi et al, 2009; J Infect Dis, 199:1327–1334
CX3CR1 rs3732378
rs3732379
0.56 0.03 32 0.96 1 1 Faure et al., 2000; Science, 287:2274–2277
CXCL12 rs1801157 rs10900029 (0.22) 0.8 7.07E-05 179 0.01 0.08 0.6 [15] Petersen et al., 2005
Modi et al., 2005; Genes Immun, 6:691–698
DARC rs2814778 1 0.1 8 0.8 1 1 He et al., 2008; Cell Host Microbe, 4:52–62
DEFB1 0.03 51 1 1 1 Braida et al., 2004; AIDS, 18:1598–1600
Milanese et al., 2006, AIDS, 20:1673–1675
IL10 rs1800872
rs1800896
0.2 0.007 18 0.13 1 1 Shin et al., 2000; Proc Natl Acad Sci USA, 97:14467–144721
Naicker et al,2009; J Infect Dis, 200:448–452
IL18 rs1946518 0.004 0.004 17 0.07 1 1 [14] Segat et al., 2006
IRF1 rs17848424 0.34 0.34 12 1 1 1 Ball et al., 2007; AIDS, 21:1091–1101
MBL2 rs5030737
rs1800450
rs1800451
0.45 0.001 297 0.3 1 1 Garred et al., 1997; Scand J Immunol, 46:204–208
Pastinen et al., 1998; AIDS Res Hum Retroviruses, 14:695–698
Boniotto et al., 2003; AIDS, 17:779–780
Vallinoto et al., 2005; Mol Immunol, 43:1358–1362
PPIA 0.03 9 0.27 1 1 An et al., 2007; PLoS Pathog, 3:e88
Rits et al., 2008; PLoS One, 3:e3975
PTPRC 0.03 188 1 1 1 Tchilian et al, 2001; AIDS, 15:1892–1894
TRIM5 rs3740996 rs10838525 rs10769175 (0.19) 0.67 0.005 23 0.12 1 1 Javanbakht et al, 2006; Virology, 354:15–27